Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Bubs Australia Ltd. ( (AU:BUB) ) has issued an announcement.
Bubs Australia reported a strong first-half fiscal 2026 result, with revenue rising 14% to $55.5 million and underlying EBITDA jumping to $4.4 million, driven largely by higher-margin U.S. sales and improved channel mix. The company maintained a solid balance sheet with $9.9 million in cash and $20 million in undrawn debt facilities, while rebuilding inventory to support demand and upgrading full-year guidance to $120–$125 million in revenue and $4–$6 million in EBITDA.
Regionally, U.S. revenue surged 48% to $34.2 million as major retailers expanded store counts and ranges, while China saw strong underlying demand but softer reported revenue of $7.5 million due to temporary inventory effects and short-term supply shortages. Australia faced stock constraints and competitive pressures, and Rest of World growth was hampered by regulatory hurdles and limited product availability, even as Bubs continued to rationalise its product portfolio and strengthen leadership to support its global growth strategy.
The most recent analyst rating on (AU:BUB) stock is a Hold with a A$0.13 price target. To see the full list of analyst forecasts on Bubs Australia Ltd. stock, see the AU:BUB Stock Forecast page.
More about Bubs Australia Ltd.
Bubs Australia Ltd. is an Australian infant nutrition company focused on premium infant milk formula and related dairy-based products. The business has a growing international footprint, with the U.S. as its largest and most profitable market, alongside operations in China, Australia and selected Rest of World markets including Japan and Vietnam.
Average Trading Volume: 635,161
Technical Sentiment Signal: Sell
Current Market Cap: A$107.3M
Learn more about BUB stock on TipRanks’ Stock Analysis page.